Clinical management and burden of bipolar disorder: Results from a multinational longitudinal study (WAVE-bd)

International Journal of Neuropsychopharmacology

Volumn 16, Issue 8, 2013, Pages 1719-1732

  Vieta, Eduard ^a   Langosch, Jens M ^b   Figueira, Maria Luisa ^c   Souery, Daniel ^d   Blasco Colmenares, Elena ^e   Medina, Esteban ^f   Moreno Manzanaro, Miriam ^f   Gonzalez, Miguel Angel ^g   Bellivier, Frank ^h  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Bethanien Hospital for Psychiatry Psychosomatics and Psychotherapy   (Germany)

^c UNIVERSITY OF LISBON   (Portugal)

^d Centre Européen de Psychologie Médicale PSY PLURIEL   (Belgium)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f ASTRAZENECA   (United Kingdom)

^g IQVIA   (United States)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Bipolar disorder; Disease management; Recurrence; Relapse

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; DEPRESSION; EUROPE; FEMALE; HEALTH CARE; HUMAN; HYPOMANIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANIA; MOOD; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RELAPSE; SOUTH AMERICA; SUICIDE ATTEMPT;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COST OF ILLNESS; DATABASES, FACTUAL; EUROPE; FEMALE; HEALTH RESOURCES; HUMANS; INTERNATIONAL COOPERATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SOUTH AMERICA; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84883016362     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713000278     Document Type: Article

References (57)

1. American Psychiatric Association (2012) Practice guideline for the treatment of patients with bipolar disorder. Second edition. http://psychiatryonline.org/data/Books/prac/Bipolar2e-Inactivated-04-16-09.pdf. Retrieved 27 Feb 2012.
2. Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH (2011) Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry 68: 791-798.
3. Baldessarini R, Henk H, Sklar A, Chang J, Leahy L (2008) Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv 59: 1175-1183.
4. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J (2007) Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv 58: 85-91.
5. Baldessarini RJ, Tondo L, Vazquez GH, Undurraga J, Bolzani L, Yildiz A, Khalsa HM, Lai M, Lepri B, Lolich M, Maffei PM, Salvatore P, Faedda GL, Vieta E, Tohen M (2012) Age at onset vs. family history and clinical outcomes in 1665 international bipolar-I disorder patients. World Psychiatry 11: 40-46.
6. Bellivier F, Yon L, Luquiens A, Azorin JM, Bertsch J, Gerard S, Reed C, Lukasiewicz M (2011) Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM). Bipolar Disord 13: 377-386.
7. Colom F, Vieta E, Martinez-Arán A, Reinares M, Benabarre A, Gastó C (2000) Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 61: 549-555.
8. Crismon ML, Argo TR, Bendele SD, Suppes T (2012). Bipolar Disorder Algorithms. Texas Medication Algorithm Project 2007. http://www.pbhcare.org/ pubdocs/upload/documents/TIMABDman2007.pdf. Retrieved 27 Feb 2012.
9. Cruz N, Sanchez-Moreno J, Torres F, Goikolea JM, Valentí M, Vieta E (2010) Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Int J Neuropsychopharmacol 13: 5-14.
10. de Dios C, González-Pinto A, Montes JM, Goikolea JM, Saiz-Ruiz J, Prieto E, Vieta E (2012) Predictors of recurrence in bipolar disorders in Spain (PREBIS study data). J Affect Disord 141: 406-414.
11. Denicoff KD, Leverich GS, Nolen GW, Rush AJ, McElroy SL, Keck PE, Suppes T, Altshuler LL, Kupka R, Frye MA, Hatef J, Brotman MA, Post RM (2000) Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med 30: 1391-1397.
12. Dennehy EB, Marangell LB, Allen MH, Chessick C, Wisniewski SR, Thase ME (2011) Suicide and suicide attempts in the systematic treatment enhancement program for bipolar disorder (STEP-BD). J Affect Disord 133: 423-427.
13. Fountoulakis KN, Gonda X, Vieta E, Rihmer Z (2011) Class effect of pharmacotherapy in bipolar disorder: fact or misbelief? Ann Gen Psychiatry 10: 8.
14. George EL, Miklowitz DJ, Richards JA, Simoneau TL, Taylor DO (2003) The comorbidity of bipolar disorder and axis II personality disorders: prevalence and clinical correlates. Bipolar Disord 5: 115-122.
15. González-Pinto A, Galán J, Martin-Carrasco M, Ballesteros J, Maurino J, Vieta E (2012) Anxiety as a marker of severity in acute mania. Acta Psychiatr Scand 126: 351-355.
16. Grande I, de Arce R, Jiménez-Arriero MA, Lorenzo FG, Valverde JI, Balanzá-Martínez V, Zaragoza S, Cobaleda S, Vieta E (2012) Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES). Int J Neuropsychopharmacol 27: 1-11.
17. Grunze H, Vieta E, Goodwin G, Bowden C, Licht RW, Möller HJ, Kasper S (2009) The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 10: 85-116.
18. Grunze H, Vieta E, Goodwin G, Bowden C, Licht RW, Möller HJ, Kasper S (2010) The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 11: 81-109.
19. Grunze H, Vieta E, Goodwin G, Bowden C, Licht RW, Möller HJ, Kasper S (2013) The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2013 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 14: 154-219.
20. Hakkaart-van Roijen L, Hoeijenbos MB, Regeer EJ, ten Have M, Nolen WA, Veraart CP, Rutten FF (2004) The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands. Acta Psychiatr Scand 110: 383-392.
21. Hirschfeld RM, Calabrese JR, Frye MA, Lavori PW, Sachs G, Thase ME, Wagner KD (2007) Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening. Psychopharmacol Bull 40: 7-14.
22. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB (2003) A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60: 261-269.
23. Kamat SA, Rajagopalan K, Pethick N, Willey V, Bullano M, Hassan M (2008) Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population. J Manag Care Pharm 14: 631-642.
24. Koukopoulos A, Pani L, Serra G, Minnai G, Reginaldi D (1995) Anxious-excited depression: a mixed affective syndrome. Encephale 21(Spec. No. 6): 33-36.
25. Lee S, Tsang A, Kessler RC, Jin R, Sampson N, Andrade L, Karam EG, Mora ME, Merikangas K, Nakane Y, Popovici DG, Posada-Villa J, Sagar R, Wells JE, Zarkov Z, Petukhova M (2010) Rapid-cycling bipolar disorder: cross-national community study. Br J Psychiatry 196: 217-225.
26. McIntyre RS, Soczynska JK, Bottas A, Bordbar K, Konarski JZ, Kennedy SH (2006) Anxiety disorders and bipolar disorder: a review. Bipolar Disord 8: 665-676.
27. Mantere O, Isometsä E, Ketokivi M, Kiviruusu O, Suominen K, Valtonen HM, Arvilommi P, Leppämäki S (2010) A prospective latent analyses study of psychiatric comorbidity of DSM-IV bipolar I and II disorders. Bipolar Disord 12: 271-284.
28. Mitchell PB, Slade T, Andrews G (2004) Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey. Psychol Med 34: 777-785.
29. National Institute for Health and Clinical Excellence (2006). Bipolar disorder - The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. NICE Clinical guideline 38. http://www.nice.org.uk/nicemedia/pdf/CG38niceguideline.pdf. Retrieved 27 Feb 2012.
30. Nivoli AM, Murru A, Vieta E (2010) Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology 62: 27-35.
31. Nivoli AM, Colom F, Murru A, Pacchiarotti I, Castro-Loli P, González-Pinto A, Fountoulakis KN, Vieta E (2011) New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord 129: 14-26.
32. Nivoli AM, Murru A, Goikolea JM, Crespo JM, Montes JM, González-Pinto A, Garcia-Portilla P, Bobes J, Sáiz-Ruiz J, Vieta E (2012) New treatment guidelines for acute bipolar mania: a critical review. J Affect Disord 140: 125-141.
33. Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I, Weiss RD, Sachs GS (2010) Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the systematic treatment enhancement program for bipolar disorder (STEP-BD). Am J Psychiatry 167: 289-297.
34. Pacchiarotti I, Valentí M, Bonnin CM, Rosa AR, Murru A, Kotzalidis GD, Nivoli AM, Sánchez-Moreno J, Vieta E, Colom F (2011) Factors associated with initial treatment response with antidepressants in bipolar disorder. Eur Neuropsychopharmacol 21: 362-369.
35. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME (2006) Predictors of recurrence in bipolar disorder: primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD). Am J Psychiatry 163: 217-224.
36. Perlis RH, Ostacher MJ, Goldberg JF, Miklowitz DJ, Friedman E, Calabrese J, Thase ME, Sachs GS (2010) Transition to mania during treatment of bipolar depression. Neuropsychopharmacology 35: 2545-2552.
37. Pini S, de Queiroz V, Pagnin D, Pezawas L, Angst J, Cassano GB, Wittchen HU (2005) Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol 15: 425-434.
38. Post RM (2009) Myth of evidence-based medicine for bipolar disorder. Expert Rev Neurother 9: 1271-1273.
39. Romero S, Colom F, Iosif AM, Cruz N, Pacchiarotti I, Sanchez-Moreno J, Vieta E (2007) Relevance of family history of suicide in the long-term outcome of bipolar disorders. J Clin Psychiatry 68: 1517-1521.
40. Rosa AR, Cruz N, Franco C, Haro JM, Bertsch J, Reed C, Aarre TF, Sanchez-Moreno J, Vieta E (2010) Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study. J Clin Psychiatry 71: 1000-1006.
41. Rosa AR, Fountoulakis K, Siamouli M, Gonda X, Vieta E (2011) Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. CNS Neurosci Ther 17: 167-177.
42. Ruggero CJ, Carlson GA, Kotov R, Bromet EJ (2010) Ten-year diagnostic consistency of bipolar disorder in a first-admission sample. Bipolar Disord 12: 21-31.
43. Saarni SI, Viertio S, Perala J, Koskinen S, Lönnqvist J, Suvisaari J (2010) Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br J Psychiatry 197: 386-394.
44. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W (1997) Modification of the clinical global impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 73: 159-171.
45. Stensland MD, Schultz JF, Frytak JR (2008) Diagnosis of unipolar depression following initial identification of bipolar disorder: a common and costly misdiagnosis. J Clin Psychiatry 69: 749-758.
46. Swann AC (2010) The strong relationship between bipolar and substance-use disorder. Ann N Y Acad Sci 1187: 276-293.
47. Tondo L, Lepri B, Baldessarini RJ (2007) Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatr Scand 116: 419-428.
48. Undurraga J, Baldessarini RJ, Valentí M, Pacchiarotti I, Tondo L, Vázquez G, Vieta E (2012) Bipolar depression: clinical correlates of receiving antidepressants. J Affect Disord 139: 89-93.
49. Valentí M, Pacchiarotti I, Rosa AR, Bonnín CM, Popovic D, Nivoli AM, Murru A, Grande I, Colom F, Vieta E (2011) Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients. Bipolar Disord 13: 145-154.
50. Valentí M, Pacchiarotti I, Bonnín CM, Rosa AR, Popovic D, Nivoli AM, Goikolea JM, Murru A, Undurraga J, Colom F, Vieta E (2012) Risk factors for antidepressant-related switch to mania. J Clin Psychiatry 73: e271-e276.
51. Valtonen H, Suominen K, Mantere O, Leppämäki S, Arvilommi P, Isometsa ET (2005) Suicidal ideation and attempts in bipolar I and II disorders. J Clin Psychiatry 66: 1456-1462.
52. Vieta E, Blasco-Colmenares E, Figueira ML, Langosch JM, Moreno-Manzanaro M, Medina E (2011a) Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study). BMC Psychiatry 11: 58.
53. Vieta E, Gunther O, Locklear J, Ekman M, Miltenburger C, Chatterton ML, Astrom M, Paulsson B (2011b) Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 14: 1029-1049.
54. World Health Organisation (2012a). World Health Report 2001: Mental Health - New Understanding, New Hope. http://www.who.int/whr/2001/en/whr01-en. pdf. Retrieved 27 Feb 2012.
55. World Health Organisation (2012b) The global burden of disease: 2004 update. http://www.who.int/healthinfo/global-burden-disease/GBD-report- 2004update-full.pdf. Retrieved 27 Feb 2012.
56. Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, Calabrese JR, Berk M, Ha K, Kapczinski F (2009) Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 11: 225-255.
57. Young LT, Cooke RG, Robb JC, Levitt AJ, Joffe RT (1993) Anxious and non-anxious bipolar disorder. J Affect Disord 29: 49-52.